The complex relationship between CD4 count, HIV viral load, trimethoprim-sulfamethoxazole prophylaxis, and skin-and-soft-tissue infection risk in patients with HIV: Insights from a causal diagram and simulation study

Vagish S. Hemmige, D. S. Lauderdale, M. Z. David

Research output: Contribution to journalArticle

Abstract

Skin and soft tissue infection (SSTIs) due to Staphylococcus aureus, particularly community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), are common in human immunodeficiency virus (HIV)-infected populations in the United States. Studies have differed as to the importance of epidemiological and immunological factors in this relationship, and have employed conflicting strategies for variable selection in multivariate analyses. Developments in causal inference methods in epidemiology have emerged in the last decade to clarify relationships between variables and identify appropriate variables to include in and exclude from multivariate analysis. In this paper, we develop a causal diagram to clarify the pathways linking CA-MRSA and HIV. We focus on the role played by trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis, prescribed to many severely immunocompromised HIV patients and potentially protective against SSTIs, which both mediates and moderates the relationship between immunological parameters and SSTI risk. We demonstrate, using simulated data, that statistical models may yield biased results if they do not account for how HIV viral load may also be a marker of adherence to TMP-SMX prophylaxis. We conclude with a proposed causal model that includes both the epidemiological as well as immunological factors that may explain the increased risk of initial and recurrent SSTI risk in HIV-infected populations.

Original languageEnglish (US)
Pages (from-to)2889-2898
Number of pages10
JournalEpidemiology and Infection
Volume144
Issue number13
DOIs
StatePublished - Oct 1 2016
Externally publishedYes

Fingerprint

Soft Tissue Infections
Sulfamethoxazole Drug Combination Trimethoprim
CD4 Lymphocyte Count
Viral Load
HIV
Skin
Immunologic Factors
Methicillin-Resistant Staphylococcus aureus
Multivariate Analysis
Statistical Models
Population
Staphylococcus aureus
Epidemiology

Keywords

  • AIDS
  • epidemiology
  • methicillin - S. aureus resistant to (MRSA)
  • skin infections

ASJC Scopus subject areas

  • Epidemiology
  • Infectious Diseases

Cite this

@article{617bccc17b4b4e2fb2690d1a002861c7,
title = "The complex relationship between CD4 count, HIV viral load, trimethoprim-sulfamethoxazole prophylaxis, and skin-and-soft-tissue infection risk in patients with HIV: Insights from a causal diagram and simulation study",
abstract = "Skin and soft tissue infection (SSTIs) due to Staphylococcus aureus, particularly community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), are common in human immunodeficiency virus (HIV)-infected populations in the United States. Studies have differed as to the importance of epidemiological and immunological factors in this relationship, and have employed conflicting strategies for variable selection in multivariate analyses. Developments in causal inference methods in epidemiology have emerged in the last decade to clarify relationships between variables and identify appropriate variables to include in and exclude from multivariate analysis. In this paper, we develop a causal diagram to clarify the pathways linking CA-MRSA and HIV. We focus on the role played by trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis, prescribed to many severely immunocompromised HIV patients and potentially protective against SSTIs, which both mediates and moderates the relationship between immunological parameters and SSTI risk. We demonstrate, using simulated data, that statistical models may yield biased results if they do not account for how HIV viral load may also be a marker of adherence to TMP-SMX prophylaxis. We conclude with a proposed causal model that includes both the epidemiological as well as immunological factors that may explain the increased risk of initial and recurrent SSTI risk in HIV-infected populations.",
keywords = "AIDS, epidemiology, methicillin - S. aureus resistant to (MRSA), skin infections",
author = "Hemmige, {Vagish S.} and Lauderdale, {D. S.} and David, {M. Z.}",
year = "2016",
month = "10",
day = "1",
doi = "10.1017/S0950268816000789",
language = "English (US)",
volume = "144",
pages = "2889--2898",
journal = "Epidemiology and Infection",
issn = "0950-2688",
publisher = "Cambridge University Press",
number = "13",

}

TY - JOUR

T1 - The complex relationship between CD4 count, HIV viral load, trimethoprim-sulfamethoxazole prophylaxis, and skin-and-soft-tissue infection risk in patients with HIV

T2 - Insights from a causal diagram and simulation study

AU - Hemmige, Vagish S.

AU - Lauderdale, D. S.

AU - David, M. Z.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Skin and soft tissue infection (SSTIs) due to Staphylococcus aureus, particularly community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), are common in human immunodeficiency virus (HIV)-infected populations in the United States. Studies have differed as to the importance of epidemiological and immunological factors in this relationship, and have employed conflicting strategies for variable selection in multivariate analyses. Developments in causal inference methods in epidemiology have emerged in the last decade to clarify relationships between variables and identify appropriate variables to include in and exclude from multivariate analysis. In this paper, we develop a causal diagram to clarify the pathways linking CA-MRSA and HIV. We focus on the role played by trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis, prescribed to many severely immunocompromised HIV patients and potentially protective against SSTIs, which both mediates and moderates the relationship between immunological parameters and SSTI risk. We demonstrate, using simulated data, that statistical models may yield biased results if they do not account for how HIV viral load may also be a marker of adherence to TMP-SMX prophylaxis. We conclude with a proposed causal model that includes both the epidemiological as well as immunological factors that may explain the increased risk of initial and recurrent SSTI risk in HIV-infected populations.

AB - Skin and soft tissue infection (SSTIs) due to Staphylococcus aureus, particularly community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), are common in human immunodeficiency virus (HIV)-infected populations in the United States. Studies have differed as to the importance of epidemiological and immunological factors in this relationship, and have employed conflicting strategies for variable selection in multivariate analyses. Developments in causal inference methods in epidemiology have emerged in the last decade to clarify relationships between variables and identify appropriate variables to include in and exclude from multivariate analysis. In this paper, we develop a causal diagram to clarify the pathways linking CA-MRSA and HIV. We focus on the role played by trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis, prescribed to many severely immunocompromised HIV patients and potentially protective against SSTIs, which both mediates and moderates the relationship between immunological parameters and SSTI risk. We demonstrate, using simulated data, that statistical models may yield biased results if they do not account for how HIV viral load may also be a marker of adherence to TMP-SMX prophylaxis. We conclude with a proposed causal model that includes both the epidemiological as well as immunological factors that may explain the increased risk of initial and recurrent SSTI risk in HIV-infected populations.

KW - AIDS

KW - epidemiology

KW - methicillin - S. aureus resistant to (MRSA)

KW - skin infections

UR - http://www.scopus.com/inward/record.url?scp=84965050009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965050009&partnerID=8YFLogxK

U2 - 10.1017/S0950268816000789

DO - 10.1017/S0950268816000789

M3 - Article

C2 - 27143243

AN - SCOPUS:84965050009

VL - 144

SP - 2889

EP - 2898

JO - Epidemiology and Infection

JF - Epidemiology and Infection

SN - 0950-2688

IS - 13

ER -